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International Mortality and Longevity Symposium
[Institute and Faculty of Actuaries, Royal Holloway, University of London, 7–9 September 2016]
Introduction
Joseph Lu, Director Longevity Science, Legal & General
This 3-day International Mortality and Longevity Symposium brought together thought leaders
across relevant disciplines to discuss the latest thinking on the drivers and future of mortality trends
in populations.
Our attendees included actuaries, demographers, modellers, medical scientists and epidemiologists.
We have gained new insights and learned new techniques from our distinguished experts in seven
plenary sessions, 16 workshops and four representatives from the IFoA’s Actuarial Research
Centre. Please click this link for their presentations: https://www.actuaries.org.uk/learn-and-develop/
events-calendar/past-events/international-mortality-and-longevity-symposium-2016
Biology of ageing
Our plenary speakers discussed the latest developments on the trend in life expectancy, biology of ageing
and potential intervention of the process of ageing. Life expectancies at birth in most developed countries
have been rising, ﬁrst driven by reduction in early and mid-life mortality rates in the two centuries leading
to around 1970s and then by reduction in older-age mortality rates until today. However, some developed
nations have experienced a notable decline in life expectancy or deceleration in the rate of increase in recent
years. Hence, a good understanding of what drives longevity and ageing in middle and older ages is
important in forecasting life expectancy. Scientists now consider ageing to be the result of accumulation of
defects in the cells and molecules in our bodies, rather than of a biological programme that drives us to
death. Researchers have differing views on the potential likelihood and impact of age-retardation tech-
nology on longevity, but there is broader agreement that priority should be placed on improving health
rather than extending lifespan. The biological process of ageing is complex, so the development of a “silver
bullet” to retard ageing faces challenges. There is scope for actuaries to consider the potential and chal-
lenges of age-retardation technology in impacting life expectancy, when they forecast population longevity.
Bigger data for better decisions
Many actuaries are responsible for risk assessment of life insurance products, pension plans or social
security schemes that involve payments in the event of illness, death or survival of people. So, data on health,
disease and death are indispensable for actuarial work. The rapid progress in computing power means that
richer data sets containing health and mortality data are now captured in the public and private sectors.
A plenary session discussed the plethora of databases that could contribute to actuarial decisions. However,
access to these health databases can be hindered by a lack of public trust, coherent regulation and effective
collaboration between the public and private sectors. Therefore, there is a need to address these issues so
that the public can beneﬁt from improved products and services as a result of insights from these databases.
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Socio-economic implications of longevity
The combination of rise in life expectancy and drop in birth rates has led to increasing proportion of
older population in the United Kingdom – a phenomenon called the ageing population. For example,
the median age in the United Kingdom has risen from 34 in 1974 to about 40 in 2014 (Government
Ofﬁce for Science, 2016). More than 70% of the rise in UK population between 2014 and 2039
is expected to come from the above 60 age group, an increase from 14.9 to 21.9 million people
(Government Ofﬁce for Science, 2016). The plenary sessions discussed how the ageing population will
have a far-reaching impact on health care, public spending and intergenerational ﬁnancial relation-
ships. Although older people are living longer, they are also living longer with disability and illness in
the UK and several EU countries. This will increase national spending on health and social care.
The UK’s public spending on state pension will increase if all aspects of pension provisions remain
the same. However, revisions of criteria for pension age and pension increases could be used to
manage spending costs. Intergenerational inequality in wealth distribution would have long-term
ﬁscal impact. For example, the proportion of homeowners for people aged 25 has dropped from
45% for those born in 1963–1967 to 20% for people of the same age who were born in 1983–1987.
The younger generations are less likely to have an occupational pension. Additionally, they have seen
lower wage growth partly due to redistribution of resources to fund the pension costs of the older
generation. Taken together, much more needs to be done to harness the beneﬁts and tackle the
challenges of ageing populations.
Conclusion
The symposium explored examples of when actuarial work can beneﬁt from closer collaboration
with other disciplines including medical sciences, demography and data sciences. There were plenty
of opportunities for networking. I trust the knowledge, skills and network that have emerged from
this symposium will help you advance your professional and research goals.
Plenary sessions
Can we live forever?
Professor Tom Kirkwood, Professor Emeritus, Newcastle
University Institute for Ageing and Professor of Biogerontology,
University of Copenhagen Center for Healthy Aging
Humanity’s enduring fascination with the idea of immortality means that any advance in research on
ageing tends to attract headlines such as “scientists discover secret of youth!” The reality is more
prosaic. Ageing is a complicated process and the sum of what we know is still dwarfed but what
remains unknown.
Nonetheless, life expectancy is still increasing, driven not by the time-honoured reductions in early
and mid-life death rates of the last two centuries, but by rapid decline in death rates of those who are
old already. We tend now to reach old age in better condition than did our ancestors, if indeed they
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reached old age at all. If ageing is amenable to improvement, as is apparently the case, what
possibilities exist further to extend our period of good quality life?
Biology reveals that there is no strict programme driving us to die, but that ageing is caused by the
gradual, lifelong build-up of small faults in the cells and molecules that make up our bodies. Genetics
plays its part, by regulating the quality of our maintenance systems, but genes account only for a
quarter of what inﬂuences the individual’s length of life. The rest comes from things like nutrition,
lifestyle, education, housing, attitude and probably much else besides.
It might turn out that scientiﬁc discoveries will one day boost our chances to enjoy health for longer,
but we should be honest in acknowledging the signiﬁcant challenges that will ﬁrst need to be
surmounted. Most of all, we need a massive effort to bring the science of ageing to fruition in helping
us to learn much more about age-related illness. What is it about the mere fact of getting older that so
greatly increases the risk of developing any one of the many chronic diseases for which age is much
the greatest risk factor?
The rise and fall of human longevity in the 21st century
S. Jay Olshansky, PhD, University of Illinois at Chicago
Olshansky started by identifying the rise in human longevity in the last 120 years as one of
humanity’s major accomplishments. The good news is that we’re living longer because in the absence
of ﬁxed genetic programmes for ageing or death, it has become possible to modify the world around
us to foster conditions that favour greater longevity.
There is reason to be optimistic that future advances in the biomedical sciences will not just continue,
but they are likely to accelerate – leading to the manufacture of additional survival time. Just how
much longer medical technology can make us live has yet to be determined.
The challenging news is that our increased longevity is accompanied by a Faustian trade – we now
live with regularity into an age window where the biological processes of ageing remain immutable,
and the fatal and disabling diseases that accompany our longer lives rise exponentially with greater
longevity. It is possible, perhaps likely, that increased longevity brought forth by the medical
advances mentioned above, could yield negative health trade-offs soon. That is, gains made against
cardiovascular diseases and cancer could expose the saved population to an elevated risk of
Alzheimer’s disease and other negative trade-offs that are undesirable and costly.
Olshansky was optimistic that interventions that modulate biological ageing are forthcoming (he is
personally supporting these ideas through the Longevity Dividend Initiative), but the biological
reality is that human bodies were not built to last. There is indeed excitement in the air about ageing
science, but this excitement must be tempered by the biological reality and recently observed trends
in mortality in long-lived populations suggesting that linear increases in life expectancy are neither
biologically nor demographically justiﬁable – especially not in the United States. Recent trends in life
expectancy in other long-lived populations, such as the United Kingdom, France and Canada,
suggest that we may be approaching a point of diminishing returns. Actuaries and demographers
need to think very carefully about their forecasting assumptions considering both Faustian trade-offs
and the underlying biology that determine lifespan potential.
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Health and longevity – can we have both?
Professor Carol Jagger, AXA Professor of Epidemiology of
Ageing and Deputy Director, Newcastle University Institute
for Ageing, Newcastle upon Tyne
Professor Jagger’s session covered trends in life and health expectancy in the United Kingdom since
2000, making comparisons with four European countries (Belgium, France, the Netherlands and
Sweden) and three OECD countries (Japan, Switzerland and the United States).
Trends in life expectancy (LE) at birth were similar for all countries considered although UK
women’s life expectancy is the lowest of the four European countries and only US women’s life
expectancy is lower.
Men’s life expectancy at birth, on the other hand, ranks higher. Whether these extra years of life are
healthy ones is the question that health expectancies can answer. Professor Jagger focussed ﬁrst on the two
main health expectancies routinely reported by the Ofﬁce for National Statistics: Healthy Life Expectancy
(HLE) based on self-rated health; and Disability-free Life Expectancy (DFLE) based on activity restriction.
In the United Kingdom since 2000 there appears to have been some compression of disability and
ill-health at younger ages, with increases in DFLE and HLE at birth being larger than increases in life
expectancy. However, the opposite is true at older ages, 65 and 85, so that the extra years of life are spent
with disability of ill-health. Trends in DFLE and HLE in other countries are much more variable than LE
with only Sweden and Switzerland showing a compression of disability or morbidity at all ages.
Professor Jagger then described the most recent ﬁndings for England, using the Cognitive Function
and Ageing Studies, on a wider range of health expectancies at age 65. She demonstrated that
conclusions about whether or not the extra years of life were healthy ones depends heavily on the
measure of health. There was a real compression of cognitive impairment between 1991 and 2011, in
keeping with the reduction in the prevalence of dementia over the same time period, and also seen in
Sweden and the United States. However, the picture for disability was much less positive with an
expansion of mild disability, a ﬁnding also evident in the United States.
Finally, Professor Jagger discussed the possible drivers of trends in DFLE in terms of health beha-
viours (obesity, smoking, physical inactivity) and chronic conditions. The discussions that followed
covered whether the smaller improvements in HLE compared to LE were perhaps due to individuals
being diagnosed earlier especially around particular targets for general practitioners. Professor
Jagger replied that this might be a contributing factor but the self-rated health on which HLE was
based was a more holistic measure and would also encompass mental as well as physical health.
Public data for the private sector
Dame Karen Dunnell, Chair, Longevity Science Panel
Dame Dunnell began by explaining that The Longevity Science Panel of Legal and General are active
users of statistical information and databases of all kinds. It was the crisis over the failure of the care.
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Data programme that led the panel to carry out their project to understand what went wrong and to
make recommendations about how to improve the situation.
The insurance industry and actuaries have always had access to anonymised information from
administrative sources like birth and death registration and Hospital Episode Statistics. Census and
survey data are also available via the Economic and Social Research Council (ESRC, UK). Access to
this data is becoming more difﬁcult.
Using the examples of an ageing population and its social care and housing needs Dunnell showed
how access to a wider range of publicly collected information could beneﬁt the development of
services and products for our ageing society.
The panel recommend:
∙ The formation of a publicly acceptable legal structure and entity to govern the collection,
management and dissemination of public statistics, data and information to support the public good.
∙ The “public good” be deﬁned in such a way that includes any activity that beneﬁts society or the
economy, particularly where that activity is aligned with public policy.
∙ Strategies are employed to improve the appropriate access of both the public and private sectors to
all publicly funded data, information and statistics, while protecting the privacy of individuals and
the public interest.
∙ Private sector and public bodies are included in discussions to specify what public data and
information are needed for the beneﬁt of society and the economy.
Demographic change and fiscal policy
Paul Johnson, Director of the Institute for Fiscal Studies
The United Kingdom is ageing. This matters to ﬁscal policy because older people are less likely to be
in employment and spending on older people is much higher than on younger people. To cope with
an ageing population the government will either have to increase taxes, or reduce spending on the
health and pensions of older people, or cut spending on other services – which have been hit
particularly hard by cuts in recent years.
Pensions
The ﬁscal impact from increased state pension spending is actually fairly manageable. Increases in the
state pension age, reﬂecting increased longevity, and ending the unsustainable “triple-lock” –
whereby pensions rise by the faster of inﬂation, earnings growth and 2.5% – could keep additional
spending on pensions down to as little as an extra 1% of national income despite the rapid growth in
numbers of older people.
Health care
The impact of ageing on health care spending is more uncertain and the additional cost will likely be
much higher than the additional cost of pension provision. The affordability of health care spending
depends not just on demographic change but is also highly sensitive to what happens to productivity
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in the health service. If productivity rises only as fast as it has over the last 50 years we could easily
see spending rise by 5% of national income over the next 40 or 50 years.
Intergenerational equity
Those retiring over the last decade or so and those retiring in the next decade have been very
fortunate economically. They have done well in the housing market and many have generous
occupational pensions. Younger people are much less fortunate. There are no deﬁned beneﬁt
occupational pensions left in the private sector and home ownership rates have collapsed as prices
have risen. Prolonged low interest rates have also made retirement savings much more challenging
than for previous generations. At the same time earnings of those in their twenties are lower than for
those at the same age more than a decade ago. The younger generation is likely to be particularly
dependent on inheritance, reducing social mobility. Policy needs to reﬂect the reduced economic
resources of this generation.
Macro-demographic perspective of longevity
Dr Amlan Roy, Systemic Risk Centre, London School of Economics
and Guest Finance Professor, London Business School
The goal of this plenary session was to highlight the important insights from quantitative ﬁnance,
investment theories, macroeconomics and behavioural ﬁnance towards a contribution to the existing
strong background of actuaries in the world of pensions. This was similar to a closing plenary speech
at the Investment Symposium of the Society of Actuaries. Understanding the big picture requires the
actuarial profession to integrate insights from the academic and applied ﬁnance/portfolio invest-
ments literature.
Dr Roy started by challenging the traditional age classiﬁcations of old, working age and young used
by economists and actuaries demonstrating that the fastest growing age group and the one
responsible for ageing related ﬁscal sustainability issues is the 80+ age group. He cited management
and pensions global guru Drucker (1999) who argued that most people do not understand demo-
graphics as they take a narrow focus. Dr Roy argues that demographics is about people char-
acteristics, of which age, is just one of the characteristics. He urged for a broader understanding of
demographics pertinent to individual characteristics as consumers and workers which underlie many
facets of deﬁned contribution and hybrid pension schemes.
He highlighted signiﬁcant divergences in longevity and demographic trends across rich countries
cautioning against broad generalisations. He raised issues regarding combining different statistical
techniques to arrive at longevity forecasts (Haberman, 2016) and also a better understanding of
international longevity differences along with their impact and effects (Gillespie et al., 2016 [2014]).
He demonstrated the challenges of global growth and showed how demographic factors affect gross
domestic product (GDP) growth and ﬁscal sustainability of the European Union, Japan and the
United States. The vast demographic divergences across emerging nations of Brazil, China, India,
Russia, Mexico and Turkey were highlighted in the context of the demographic dividend theory
which posits contribution of demographics to GDP per capita.
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Also illustrated were the bigger issues of youth unemployment and gender disparity across countries
and regions of the world. Their amelioration (or elimination) is essential for unblocking the growth
and equity prospects of the world. The role of macro demographics in inﬂuencing interest rates and
the ineffectiveness of current monetary policy was argued.
Quantitative links of demographics to savings, investment and current account were illustrated in
order to explain the global linkages in an interconnected world which is changing in a post Brexit
and likely post Trump world. Further quantitative investment implications through sectors that were
demographically advantaged and macro-asset allocation changes were also stressed.
In conclusion, Dr Roy stressed the need to understand dynamic macroeconomics, portfolio theory,
quantitative ﬁnance and behavioural economics is critical for actuaries, investors and policy-makers as the
top-down dynamic effects are critical for strategic asset allocation and strategic Asset Liability Manage-
ment. This would complement the existing actuarial and biomedical approaches to pensions.
Causal model for mortality, morbidity and longevity
Dr Chris Martin, Clinical Modelling Consultant at L&G.
Joseph Lu, Director, Longevity Science, Legal & General.
Matthew Edwards, Head of Mortality and Longevity,
Life Insurance Practice, Willis Towers Watson
Dr Chris Martin focussed on causal models for mortality, their use in medicine and how they might
translate to the retirement products domain. He began by outlining the history of mathematical and
computer modelling in the medical literature and how it has developed over time.
He described medical uses of regression models, Bayesian systems, neural networks, Markov models,
“expert systems” and other logical rule-based methods, as well as discrete event simulation.
He ﬁnished with tips on how to exploit the medical literature for parameterisation of cause-of-death
models.
In summary, regression models had clearly dominated the ﬁeld and continued to do so. Interest in
early rule-based “expert systems” was in relative decline, though newer methods such as classiﬁ-
cation and regression trees had potential for application in underwriting. Looking to the future,
discrete event simulation is used increasingly in the modelling industry supporting economic eva-
luation of new drugs, and may supplant Markov modelling as the dominant method.
Joseph Lu discussed some emerging drivers that offer opportunities for actuaries to serve the public
through providing mortality, morbidity and longevity assumptions. These drivers include:
∙ Increasing demand for de-risking of the global-deﬁned beneﬁt pension funds, estimated at $10
trillion. Actuaries will need to estimate current future mortality rates of pensioners in different
socio-economic groups.
∙ In the United Kingdom, average age is rising, but people are not saving enough. Over 60s have c.£1.3
trillion in housing equity, increasingly used to ﬁll saving gaps. Examples of newer products include
lifetime mortgage that requires assumptions for care home entry and mortality rates of customers.
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∙ Pressure on public ﬁnances is moving the provision of welfare from the state to individuals and
employers, needing private provision of protection products such as critical illness, income
protection and life insurances.
∙ Rising wealth in developing countries with less comprehensive state health care provision.
Projections of future longevity could draw upon techniques from a range of ﬁelds, including
statistics, medical science, epidemiology and demography. Population trends can also be broken
down into subpopulations to examine mortality rates according to gender, socio-economic status or
health condition. There are opportunities for actuaries to work with other disciplines to develop
forecasting methods that take account of drivers of longevity and morbidity.
Matthew Edwards discussed his recent development of a disease-based Markov model simulating
the mortality process through transitions from healthy to disease to death, or from other starting points.
This has obvious uses in a medical underwriting context, but can also add insights in the
ﬁeld of longevity improvements. Through a pool of medical experts, the likely improvement trend
for each transition (for instance, from healthy to diabetes, or from stroke to death) can be
quantiﬁed with suitable rationale to allow proper discussion as to the suitability of the assumptions. The
model then provides a framework to combine those trends across all diseases and all state transitions.
Matthew illustrated some of the results obtained from this work. For instance, the model was able to
quantify the expected female mortality improvements as a proportion of male improvements (circa
60%–90% over a typical pensioner age range), and also able to segment the proportions of overall
improvements attributable to improvements in morbidity as opposed to improvements in mortality
from the disease state (the split was ~15% morbidity: 85% mortality).
Workshop sessions
Coherent mortality projections for the Netherlands taking
into account mortality delay and smoking
Fanny Janssen, Population Research Centre, University of
Groningen, the Netherlands
Recent analyses of mortality trends reveal a transition from mortality compression (a changing shape
of the age-at-death distribution with more deaths occurring around the modal age at death) towards
mortality delay (a shift in the age-at-death distribution towards older ages) (e.g. Janssen and de Beer,
2016). Mortality projections including this shift have been applied before, albeit very rarely, and
only for single populations/countries. Also these mortality projections did not account for the
effect of smoking, whereas smoking is known to greatly affect future mortality trends and levels
(e.g. Janssen et al., 2013). Recently developed coherent mortality projections have not been applied
much, let alone in combination with smoking and mortality delay.
The speaker proposed a mortality forecasting methodology which simultaneously takes into account
the effect of smoking, mortality delay and mortality compression, and the mortality experience of the
opposite sex and of other countries. She illustrated the methodology with a mortality forecast for the
Netherlands. See Janssen & de Beer (2016) for more details.
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For the Netherlands, the necessity of taking into account smoking when performing projections
based on mortality delay clearly showed. That is, compared to all-cause mortality, for non-smoking-
related mortality increases in the modal age at death – indicating mortality delay – are much more
linear, and more similar for men and women. The coherent mortality projection for the Netherlands
which took into account both mortality delay and smoking resulted in higher remaining life
expectancy at age 40 in 2050 and more deaths at higher ages compared to a conventional
(Lee–Carter) projection and the forecast by Statistics Netherlands. The Lee–Carter model seems not
able to fully capture the (continued) delay.
Extreme scenarios for pandemic risk
Dr Gordon Woo, Catastrophist, Risk Management Solutions
Dr Woo gave a presentation on extreme scenarios for pandemic risk. He started by pointing out that
it is almost a century since the last catastrophic inﬂuenza pandemic. The most recent inﬂuenza
pandemic was also H1N1, and occurred in 2009. Because this was mild, there is a psychological
outcome bias towards people downgrading pandemic risk as a cause of mass excess mortality.
Dr Woo stressed that in order to understand the scope of pandemic risk, the spectrum of possible
future scenarios needs to be constructed based on the current human population and infectious
disease environment. This structured approach to dynamic modelling is more insightful for risk
management than a purely statistical method. Intrinsic to this approach is the maximal incorporation
of medical and public health knowledge.
Of particular actuarial interest for life insurers are the extreme pandemic scenarios. A benchmark for
a pandemic of insurance catastrophe proportions is the 1918 pandemic. Many more died of the
inﬂuenza pandemic than in the Great War itself. Dr Woo made a special note, which is signiﬁcant for
risk assessment, that the two global disasters were causally connected. The inﬂuenza was brought to
the western front by a cohort of 100,000 Chinese labourers despatched there by the Chinese gov-
ernment seeking favour from the western powers.
The nexus between political conﬂict and a global pandemic provides one clear route to disaster. Dr Woo
was asked about current extreme scenarios of this kind. In response, he cited the counterfactual possi-
bility in 2015 that an emerging Middle East respiratory syndrome outbreak in the Middle East might
have developed into a pandemic through the migration of a million refugees into Europe. He also
commented that it was fortunate there was no civil war in West Africa when Ebola struck in 2014.
Medical innovation versus Risk factors: a future perspective
on breast and lung cancer
Nicola Oliver, Medical Director and Head of Longevity and
Mortality Research, Medical Intelligence (UK) Ltd
The last 30 years have witnessed signiﬁcant advances in medical treatments for some, but not all,
cancers. Similarly, changes in lifestyle behaviour risk factors, both positive and negative, have
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affected disease risk. Breast cancer and lung cancer were selected for closer scrutiny due to their
contrasting proﬁles in terms of survival and mortality.
In the ﬁrst half of this session, the impact of medical treatments, speciﬁcally combination therapy and
targeted therapy, in the management of breast and lung cancer were explored in order to understand
the impact of treatments on prognosis.
Breast cancer is generally diagnosed at early stages thus enabling timely and effective treatment, as
compared with lung cancer, in which late stage diagnosis results in poor prognosis, survival and high
mortality rates. This has resulted in improving mortality rates for breast cancer over time, and,
ironically, increasing incidence as many more cancers at early stages are identiﬁed. Lifestyle risk
factors such as obesity and smoking rates were discussed in relation to their impact on disease risk.
In the latter part of the session, the future impact of risk behaviours including smoking, obesity,
alcohol intake and sedentary behaviour were discussed in relation to their impact on disease risk and
survival. Their impact was examined against the backdrop of improving medical innovation and
diagnostics.
In conclusion, obesity and smoking represent continuing threats to future disease risk; however,
potential modifying factors including improved screening and diagnostics and the ever expanding
impact of targeted therapies will potentially triumph over the negative impact of lifestyle risk
behaviours, particularly in light of continued public health efforts to combat smoking and
obesity rates.
Use of routinely collected primary care data to model
longevity and longevity improvement
Professor Elena Kulinskaya and Lisanne Gitsels, University
of East Anglia
This workshop session was focussed on how statistical modelling of population-based health data
measured at individual level could be used to assess longevity risks and how actuarial data could
then be used to translate the results to the population of interest to the actuarial community.
Professor Kulinskaya discussed her new research programme (2016–2020) funded by the Institute
and Faculty of Actuaries (IFoA). The aims of the research programme are to identify and quantify the
key factors affecting mortality and longevity, such as lifestyle choices, medical conditions and/or
interventions; modelling of temporal changes in the factors affecting morbidity and mortality; eva-
luation of plausible scenarios in mortality trends of insureds due to medical advances or lifestyle
changes; and development of software tools to forecast longevity risk. The aims will be addressed
using The Health Improvement Network (THIN) primary care data and the Continuing Mortality
Investigation actuarial data.
Lisanne Gitsels discussed a case-study on longevity improvement attributable to the widening of the
prescription of statins under recently revised National Institute for Health and Care Excellence
criteria. The results are based on the preliminary research within Professor Kulinskaya’s research
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programme and published in Gitsels et al. (2016). Using THIN data, four cohorts aged 60, 65, 70 or
75 years with no previous history of cardiovascular disease were studied, with sample sizes 118,700,
199,574, 247,149 and 194,085, respectively. The results demonstrated that the already eligible
patients (QRISK2 of ≥20%) had a life expectancy improvement of 14%–18% if prescribed statins
by the age of 65, the newly eligible patients (QRISK2 of 10%–19%) had an improvement of
11%–21% if prescribed statins by the age of 70, and the non-eligible patients (QRISK2< 10%) had
no improvement by any age. The improvements attributable to statin use translated to an increase in
life expectancy of 1.2–2 years.
Inferences for maximum country life expectancy using
provincial data
Anthony Medford, Max Planck Odense Centre on the
Biodemography of Aging, University of Southern Denmark
The most popular mortality forecasting models, the Lee–Carter Model (Lee & Carter, 1992) and its
numerous extensions and variants ﬁt trends to age-standardised (log) death rates. However, there is a
strong argument for using life expectancy in forecasting. White (2002) found that linear trends in life
expectancy give a better empirical ﬁt to the experience of individual countries than linear trends in
age-standardised (log) death rates in his study of 21 developed countries.
Global Best Practice Life Expectancy (BPLE) is the maximum life expectancy observed among
nations at a given age. Can the notion of BPLE be could be extended to regions smaller that the
global whole and what kinds of conclusions can be drawn? A new approach to modelling and
projecting (maximum) life expectancy for an arbitrary region using only data from the sub regions
was explored by applying ideas from the statistical theory of Extreme Values. The method was
applied to the Canadian provinces and Japanese prefectures using high-quality data from the
Canadian and Japanese Mortality Databases.
One advantage of the approach is that it is possible to make probabilistic statements about future
maximum Canadian life expectancy. Second, we are able to project maximum life expectancy for a
country, say by using only information about life expectancy at the provincial level. This method
could be applied in other situations where regional-only data are available but one would like to
have an idea about life expectancy at a supra-regional or more aggregated level. One key theoretical
challenge, however, is in dealing with the high correlation between sub regional life expectancy, and
research on this problem is ongoing.
Explaining the “Female Longevity Puzzle”
Malene Kallestrup-Lamb, PhD, Centre for Research in
Econometric Analysis of Time-Series, Aarhus University
This paper analyses the complexity of female longevity improvements by using detailed register data
for Denmark and Norway. The aim of this paper is two-fold; ﬁrst, we identify which socio-economic
groups have been driving the standstill in life expectancy and analyse which causes of deaths have led
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to this standstill. Second, we investigate the forecast implications of using sub-group data and
compare the performance of the single-population Lee–Carter model (Lee & Carter, 1992) with the
multi-population Li and Lee model (Li & Lee, 2005).
It is found that the decline in life expectancy for Danish women is present for all sub-groups,
however, with particular large decreases for the low-middle and middle afﬂuence groups. We ﬁnd
that causes of deaths related to smoking are contributing to the slowdown in female longevity as
low-middle and middle afﬂuence groups display higher increases in death rates for smoking-related
causes of deaths.
However, the following catch up effect starting from 1995 is mainly driven by the signiﬁcant drop in
causes of deaths relating to the circulatory system with ischaemic heart diseases. Thus, the political
decision to add signiﬁcant funding to this area has proven highly beneﬁcial in terms of gains in life
expectancy for females.
Continuous Mortality Investigation (CMI) update on longevity
modelling and high age mortality
Tim Gordon, Head of Longevity, Aon Hewitt
Steve Bale, Prudential Risk Actuary, Legal & General,
presenting on behalf of the CMI
The Mortality Projection Committee has updated its Mortality Projection Model as follows:
∙ age, period and cohort components of mortality improvement are now modelled explicitly, which
means they can be disaggregated into age–period and cohort components in a single step;
∙ users can adjust the responsiveness of the Model to new data using a single “period smoothing
parameter”;
∙ the long-term improvement rate tapers to zero earlier and quicker (between ages 85 and 110
compared to ages 90 and 120 previously); and
∙ although the CMI takes the view that allowing for the slope of mortality improvements (“direction
of travel”) does not make for robust projections, it is now straightforward for users to incorporate
this if they choose.
Since the symposium, the CMI has completed its consultation and published a revised version of the
proposed model. The ﬁrst ofﬁcial version is expected to be published in March 2017, based on England
and Wales data to the end of 2016. Further details can be found in Working Papers 90, 91 and 93.
The High Age Mortality Working Party provided an update on their framework for closing mortality
rate tables at very high ages. The approach focusses on graduating portfolio mortality data where
there are sufﬁcient volumes, with population mortality data being used to inform higher age
behaviour where there is evidence of convergence between the two data sets. At the very highest ages,
population data may not be available or credible, so expert judgement will be required to set a
plausible level and shape to mortality rates. The Working Party intends to summarise its proposed
approach in a working paper in 2017.
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The Working Party has also been considering the impact of modelling variants on the Kannisto–
Thatcher approach to estimating population data at high ages. These variants include modelling
recent mortality trends and lowering the join age at which the Kannisto–Thatcher (Thatcher et al.,
2002) approach commences. We intend to report on our ﬁndings in 2017.
Stochastic mortality forecasting with smoothing and
over-dispersion
Professor Jon Forster, Professor of Statistics, Department of
Mathematical Sciences and ESRC Centre for Population
Change, University of Southampton
In this session, the author gave details of work carried out at Southampton University, commissioned
by the Ofﬁce for National Statistics, on a mortality forecasting framework. The goal of the research
was to overcome several of the limitations associated with existing approaches. One such issue is
those errors in models which do not adequately ﬁt the data can lead to estimates and forecasts which
over-ﬁt ﬂuctuations in the data and are insufﬁciently robust.
Another feature, lacking in many existing approaches, is the facility to impose smoothness in
parameter series which vary over age, cohort and time. This is integrated into the modelling process,
by the use of generalised additive models (GAMs), rather than being performed in a post hoc fashion.
GAMs are a ﬂexible class of semiparametric statistical models which allow parametric functions and
unstructured (but smooth) functions of explanatory variables to appear in the model simultaneously.
The presentation explored the potential of GAMs for mortality modelling and forecasting. In
particular, GAMs allow us to differentially smooth components, such as cohorts, more aggressively
in areas of sparse data for the component concerned. While GAMs can provide a reasonable ﬁt for
the ages where there is adequate data, estimation and extrapolation of mortality rates using a GAM
at higher ages is problematic due to high variation in crude rates. At these ages, parametric models
can give a more robust ﬁt, enabling a borrowing of strength across age groups. The presentation
described how the authors extended an approach they had developed for graduating the English life
table, ELT17 (Ofﬁce for National Statistics), to provide a forecasting methodology based on a
smooth transition between a GAM at lower ages and a fully parametric model at higher ages.
On Bayesian two-population mortality models for the
assessment of basis risk in longevity hedges
Andrés M. Villegas, ARC Centre of Excellence in Population
Ageing Research (CEPAR), University of New South Wales,
Sydney, Australia
Index-based hedges have the potential for providing pension funds and annuity providers with an
effective solution for the management of their longevity risk. However, the lack of an appropriate
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and applicable approach for quantifying the basis risk emerging from the potential mismatch
between the mortality in the index reference portfolio and the pension fund/annuity book being
hedged is one of the main obstacles that prevent many pension schemes and insurers from
progressing in their consideration of index-based solutions. Two-population stochastic mortality
models allow the joint modelling and projection of the mortality of the reference and target
populations providing a possible approach to overcome this obstacle. However, often the portfolio
experience data will be sparse, posing a challenge for the accurate calibration and projection of
two-population models using standard estimation techniques. This presentation aimed to illustrate
how a Bayesian estimation framework can be used to deal with some of the data limitation arising in
the application of two-population stochastic mortality model for the assessment of basis risk in
longevity hedges.
The speaker ﬁrst formulated under a Bayesian framework several two-population extensions
of the well-known Lee–Carter (Lee & Carter, 1992) and Cairns–Blake–Dowd (Cairns et al., 2006)
models and then contrasted the performance of the Bayesian estimation approach with that of
the more traditional maximum likelihood estimation approach. This was done using illustrative
hedge-effectiveness evaluation exercises while paying particular attention to the impact that different
volumes of data may have on the assessment of basis risk. The results of this comparison showed
that the sampling noise present in mortality data sets with limited exposures implies signiﬁcant
parameter estimation error in the calibration of two-population mortality models and, if not
appropriately handled, can lead to a misestimation of longevity basis risk. A Bayesian estimation
approach – which accounts naturally for parameter uncertainty – results in a more accurate
assessment of the hedge effectiveness of index-based solutions for pension schemes with a small
population.
When is a cohort not a cohort? Spurious parameters in
stochastic longevity models
Jon Palin, Barnett Waddingham
Cohort effects (mortality improvements that vary by birth year) are seen in historical data for many
countries. As a result, it is natural to reﬂect them by including cohort parameters in stochastic
longevity models. However, the speaker showed that, for some models, cohort parameters are
“spurious” artefacts of the model rather than reﬂecting genuine cohort effects.
To demonstrate this, a synthetic data set is considered. This is constructed so that it has key
stylised features of historical mortality data (mortality rates that increase with age and decrease
with time, with lower mortality improvements at the oldest ages) but has no cohort effect.
Fitting the age–period–cohort (APC) model to this synthetic data set produces cohort
parameters, even after allowing for identiﬁability constraints, despite the lack of cohort effects
in the data.
The cohort parameters that arise from ﬁtting the APC model to real data are similar to those from
ﬁtting to the synthetic data set. This shows that the parameters ﬁtted to real data primarily reﬂect
spurious features of the APC model rather than genuine cohort effects. Similar problems are seen for
other models, including the Cairns–Blake–Dowd M6 model (Cairns et al., 2006) and the cohort
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extension of Lee–Carter (Lee & Carter, 1992). Jon demonstrated algebraically how the spurious
cohort parameters arise from the structure of the APC model, and how they are driven by the slope
of mortality improvements by age.
Projecting these ﬁtted parameters using the standard approach in the existing literature would give
misleading results: the time-series typically used do not take account of the quadratic shape of the
parameters. This ﬁnding explains the published result that the APC model produces materially higher
life expectancies than some other models. This has previously been described as an example of model
risk, but the speaker instead considers it to be a fundamental weakness of the structure of the
APC model.
Socio-economic differentials in multimorbidity and health
expectancy using electronic health records: methodological
challenges
Dr Madhavi Bajekal and Mei Sum Chan, Institute of
Epidemiology and Health Care, University College London
This research provided novel insights into how differences in the age of disease onset and the
subsequent pace of progression to multiple diseases and death contribute to inequalities in life
expectancy; and proposed that, with more people living for longer, insurers need to move beyond the
single-disease analysis framework for underwriting.
Linked medical records of 1.3 million English patients aged 45+ in 2001 registered in GP practices in
the Clinical Practice Research Datalink were used in the study. Patients were followed-up to March
2010. The methodological challenges (and solutions) presented included: assessing population
representativeness of the sample; which, and how many, chronic diseases to include in the analysis
(30 major chronic diseases were selected) and lastly, which modelling methods to use.
A patient having two or more diseases concurrently (of the 30 diseases in-scope) was deﬁned as being
multimorbid.
Two models were selected and analysis performed based on a count of the number of diseases a
patient has or progresses through (disease counts serving as an approximation of morbidity level):
∙ Cox proportional hazard model: this model calculated hazard ratios and survival probabilities
to estimate life expectancies by baseline morbidity level and deprivation, adjusted for smoker
status and stratiﬁed by gender. Higher levels of morbidity, being a smoker and being
disadvantaged all made a signiﬁcant independent contribution to the gap in life expectancy in
the order listed.
∙ Multi-state model: this was used to partition total life expectancies into time spent with
and without multimorbidity, for each deprivation, sex and smoker status sub-group. The
onset of multimorbidity and death occurred at younger ages for the most deprived; but this
is not attributable solely to socio-economic differences in smoking prevalence. For the
same smoking status, the most deprived men still became multimorbid earlier and died at
younger ages.
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Parameter risk in time-series mortality forecasts
Torsten Kleinow, Heriot-Watt University, Edinburgh;
Stephen Richards, Longevitas Ltd
The ongoing macroeconomic environment of low interest rates makes life-insurer and pension
scheme reserves particularly sensitive to changes in expectations of future mortality. The projection
of mortality is therefore an essential part of valuing liabilities in life insurance portfolios and pension
schemes. Since the future is inherently uncertain, an important tool for risk management and
solvency purposes is a stochastic projection model. In their presentation and accompanying paper,
Kleinow & Richards (2016) demonstrate some practical aspects of using time-series models in
assessing risk.
The ﬁrst practical result is that ARIMA models can be better representations of mortality time-series
than simple random-walk models. This is certainly the case for the example of males in the United
Kingdom over the past 40 years. The second result relates to the sometimes-overlooked issue of
parameter risk in time-series models; Kleinow & Richards (2016) give formulae for decomposing
overall risk in a forecast into undiversiﬁable trend risk (parameter uncertainty) and diversiﬁable
volatility. Using the bootstrap approach from Pascual et al. (2004), Kleinow & Richards (2016) ﬁnd
that, while certain kinds of parameter risk are negligible, others are too material to ignore. In the
speciﬁc example of UK males, the best-ﬁtting ARIMA model for a Lee–Carter time index also had
the greatest parameter uncertainty. A consequence of this was that the best-ﬁtting model led to the
highest capital requirements for a 1-year, value-at-risk assessment of risk capital. Insurers operating
under Solvency II and similar regimes therefore need to consider parameter risk in their mortality
forecasting model.
A more detailed discussion can be found in Kleinow & Richards (2016): parameter risk in time-series
mortality forecasts, Scandinavian Actuarial Journal, Published online, http://dx.doi.org/
10.1080/03461238.2016.1255655
Forecasting socio-economic differences in the mortality
of Danish males
Professor Andrew Cairns, Director of the Actuarial Research
Centre, Institute and Faculty of Actuaries
This research analysed the mortality of Danish males, subdivided into ten socio-economic groups, to
infer mortality dynamics of different sub-groups that might be mimicked in other countries. Statistics
Denmark provides a rich resource of accurate and very detailed information about all Danish
residents. The research involved data for males age 55–94 in 1985–2012, and incorporated a new
measure of afﬂuence based on individual income and wealth.
The model was an extended CBD model with a non-parametric base table and it ﬁtted well without a
cohort term. The ﬁtted model demonstrated good separation between deciles across all years and
improved plausibility compared with other models that had used income instead of afﬂuence. There
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was evidence of divergence between groups over time, despite Denmark’s reputation for progressive
social policies. The results were bio-demographically reasonable, as more afﬂuent deciles had lower
mortality, and mortality converged across deciles at higher ages. Results were simulated for various
time periods and it was demonstrated that the correlation between a particular group and the total
population increased over time, even when allowing for parameter uncertainty. The term structure of
correlations was also demonstrated to be more plausible than those of some other models; this was
true for individual deciles and amalgamated deciles.
The modelling framework allows a larger number of smaller sub-groups to be modelled than
previously possible without losing the essential character of the underlying data. This data set and
model can be used to investigate a variety of risk measurement and management problems, including
basis risk and economic capital assessment.
Evidence and implications of socio-economic differences
in mortality
Jessica Mosher, Private Pensions Analyst, Organisation for
Economic Co-operation and Development (OECD)
This session presented the main ﬁndings of a paper published in the OECD Business and Finance
Outlook 2016, which provided evidence of the differences in life expectancy at retirement for several
OECD countries and discussed the implications that these differences may have for pension and
annuity providers.
These differences in life expectancy present a challenge for pension and annuity providers to
establish accurate mortality assumptions to value their liabilities. Using average measures of
mortality for the population will likely not be accurate for subsets of the total population, yet often
more granular data on mortality is not available. Further, external shocks such as changes to pension
policy may affect the socio-economic characteristics of the population for which mortality
assumptions are being developed, implying that historical averages may not be applicable
going forward.
The tendency for pensioner and annuitant populations to be skewed towards higher economic
groups also presents a challenge for providers to mitigate their longevity risk exposure. Evidence
shows that not only do higher socio-economic groups live longer; they have often also experienced
higher mortality improvements than those in lower socio-economic groups. This leads to a greater
risk to pension and annuity providers of underestimating future mortality improvements and the
mitigation of this risk becomes more expensive.
Nevertheless, differences in life expectancy may also present providers with an opportunity to better
tailor pension products to different socio-economic groups, as has happened in the United Kingdom
with the increased prevalence of enhanced annuities, which pay higher incomes to individuals with
lower than average life expectancies. However, the discussion with workshop participants high-
lighted the tension between offering products priced and tailored very speciﬁcally to individual
characteristics and risk proﬁles, and the policy objective of risk-sharing and solidarity, in particular
with respect to longevity and pensions.
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Should behavioural and psychological factors be used
to assess mortality risk?
Peter Banthorpe, Global Head of Research and Data
Analytics, RGA
Chris Falkous, Biometric Research Actuary, RGA
When assessing mortality risk, insurers have historically focussed on traditional biometric risk factors.
This session looked at two behavioural/psychological drivers of mortality – personality and subjective
well-being – and considered the possibility of incorporating these into mortality risk assessment processes.
Personality
Personality can be thought of as the relatively stable set of traits, thoughts, feelings and behaviours
that make a person unique. A reliable and valid way to measure personality is to assess individuals
against the Big Five personality traits:





Research going back to the 1990s has shown that one of these – conscientiousness – is a strong predictor
of mortality risk even when controlling for many factors already used in mortality risk assessment.
Subjective well-being
Subjective well-being (SWB) is research-language for the different aspects of “happiness”. The
evidence that SWB inﬂuences health and longevity is compelling. Researchers have found that having
a strong sense of purpose and meaning in life can signiﬁcantly reduce mortality risk even when
controlling for many factors already used in mortality risk assessment.
Data sources for objectively measuring personality and SWB
Gathering and validating information on conscientiousness and SWB directly can be difﬁcult. Is it
possible to measure proxy objective behaviours and use these in insurance risk assessment?
An example is TransUnion TrueRisk® Life, developed by RGA and TransUnion. TrueRisk® Life
illustrates how credit data can be remodelled into a highly predictive differentiator of mortality risk,
which reﬂects the fact that it is a good proxy for conscientiousness.
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From an insurance risk assessment point of view, all have potential issues around the level of
intrusiveness into peoples’ lives.
The presentation ﬁnished with a review of considerations for acceptable data use in insurance
applications including regulations, reasonable expectations, risks and rewards.
Does money buy you longevity?
Steven Baxter, Head of Longevity Innovation and Research,
Hymans Robertson LLP
Higher-income pensioners carry disproportionate weight in pension scheme and insurance company
valuations. This session focussed on developing understanding of baseline longevity, improvements
and risk management solutions for high earners.
Baseline longevity
The speaker highlighted how baseline longevity rises with afﬂuence. Using Club Vita’s large
proprietary data set of UK deﬁned beneﬁt (DB) pensioners (c. 25% of all UK DB pensioners) it was
found that at low incomes life expectancy rises quickly with income. However, there comes a point
where the life expectancy beneﬁt of each £1,000 of income reduces. This relationship is clearest when
using (pre-retirement) salary rather than pension as the income measure.
The beneﬁt of using salary to measure afﬂuence in avoiding “socio-economic drift” was highlighted.
The historical lack of pension escalation alongside the accrual history within DB pension schemes
means that a pension of £5,000 payable to someone currently aged 90 is – in afﬂuence terms – much
more than £5,000 payable to a current 65-year old. Using pension amount to group individuals can
overstate the life expectancy of younger pensioners, as the base table implicitly “drifts” to a higher
socio-economic group at older ages.
Longevity improvements
Since the 2000s there has been a narrowing of the longevity gap between socio-economic groups.
Ofﬁce for National Statistics (ONS) data highlights how the gap between “managerial and profes-
sional” and “routine and manual” workers narrowed between the 1997–2001 and 2002–2006 data.
However, changes to the ONS classiﬁcation of socio-economic groups have limited the ability to
monitor this more recently.
Club Vita has previously identiﬁed three socio-economic groups for men (two for women)
who experienced profoundly differently longevity trends between 2000 and 2010. Those living
in the more deprived areas (the “hard-pressed”) have been catching up with the more afﬂuent
socio-economic groups (our “comfortable” group). The speaker revealed how this convergence
has continued into the 2010s. Between 2000 and 2013 the gap in life expectancy at age 65 has
narrowed by 0.8 years for men (0.4 years for women). The slower longevity improvements
for the comfortable group are particularly important for pension schemes and Bulk Purchase
Annuity life insurers, where typically 50%–80% of annual pension outgo is concentrated in the
“comfortable” group.
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Top-slicing risk management
“Top-slicing”, whereby the individuals representing the top (say) 20% of liabilities in a pension
scheme are bought-out is a popular approach to longevity risk management. However, concerns are
raised around the attractiveness of the residual liabilities for future buy-out or longevity reinsurance.
The session illustrated how, for well-designed top-slicing, there need be no anti-selection concerns.
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